Literature DB >> 26758858

Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.

Qianqian Wei1, Zhenzhen Zheng1, Xiaoyan Guo1, Ruwei Ou1, Xueping Chen1, Rui Huang1, Jing Yang1, Huifang Shang2.   

Abstract

To determine the prevalence of depression, to identify correlated factors for depression, and to explore the impact on the progression or survival of amyotrophic lateral sclerosis (ALS) by depression in a Chinese population. A total of 166 ALS patients were recruited. Diagnosis of depression disorders and the severity of depression were established by using the fourth diagnostic and statistical manual of mental disorders, Hamilton Depression Rating Scale-24 items (HDRS-24) and Beck Depression Inventory (BDI). Major depression was found in 15 patients (9.6 %). The multiple regression analysis showed that a lower ALS Functional Rating Scale-Revised (ALSFRS-R) score was correlated with increasing HDRS scores and BDI scores (P = 0.018 and P = 0.012). No significant difference in the median survival time between ALS patients with and without depression was revealed by Kaplan-Meier analysis (log-rank P = 0.282). Cox hazard model showed that the presence of depression in ALS was unrelated to the survival, while the severity of depression in ALS was correlated with the survival. The presence and severity of depression in ALS did not correlate with the progression of ALS. Major depression in ALS is uncommon. Depression evaluation should be given to ALS patients, especially those with lower ALSFRS-R score. The severity of depression may be associated with the survival; however, depression does not worse the progression of ALS.

Entities:  

Keywords:  ALS Functional Rating Scale-Revised (ALSFRS-R); Amyotrophic lateral sclerosis; Depression; Progression; Survival

Mesh:

Year:  2016        PMID: 26758858     DOI: 10.1007/s10072-015-2472-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  40 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Cohort Study.

Authors:  Federica Edith Pisa; Giancarlo Logroscino; Anica Casetta; Laura Cecotti; Lorenzo Verriello; Alessio Bratina; Arianna Sartori; Lucio Lazzarino de Lorenzo; Roberto Eleopra; Fabio Barbone
Journal:  Neuroepidemiology       Date:  2015-03-05       Impact factor: 3.282

3.  Prevalence of depressive disorders and change over time in late-stage ALS.

Authors:  J G Rabkin; S M Albert; M L Del Bene; I O'Sullivan; T Tider; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

4.  EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.

Authors:  Peter M Andersen; Sharon Abrahams; Gian D Borasio; Mamede de Carvalho; Adriano Chio; Philip Van Damme; Orla Hardiman; Katja Kollewe; Karen E Morrison; Susanne Petri; Pierre-Francois Pradat; Vincenzo Silani; Barbara Tomik; Maria Wasner; Markus Weber
Journal:  Eur J Neurol       Date:  2011-09-14       Impact factor: 6.089

5.  Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy.

Authors:  G M Galeazzi; S Ferrari; G Giaroli; A Mackinnon; E Merelli; L Motti; M Rigatelli
Journal:  Neurol Sci       Date:  2005-10       Impact factor: 3.307

6.  Quality of life, anxiety and depression in ALS patients and their next of kin.

Authors:  Anneli G Olsson Ozanne; Susann Strang; Lennart I Persson
Journal:  J Clin Nurs       Date:  2010-11-26       Impact factor: 3.036

7.  Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria.

Authors:  Mark Zimmerman; Joseph B McGlinchey; Diane Young; Iwona Chelminski
Journal:  J Nerv Ment Dis       Date:  2006-03       Impact factor: 2.254

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 9.  A review of psychosocial aspects of motor neurone disease.

Authors:  Janet E McLeod; David M Clarke
Journal:  J Neurol Sci       Date:  2007-04-19       Impact factor: 3.181

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  3 in total

Review 1.  The Impact of Cognitive and Behavioral Symptoms on ALS Patients and Their Caregivers.

Authors:  Jashelle Caga; Sharpley Hsieh; Patricia Lillo; Kaitlin Dudley; Eneida Mioshi
Journal:  Front Neurol       Date:  2019-03-11       Impact factor: 4.003

2.  Effects of Subthalamic Nucleus Deep Brain Stimulation on Depression in Patients with Parkinson's Disease.

Authors:  Tianqi Hu; Hutao Xie; Yu Diao; Houyou Fan; Delong Wu; Yifei Gan; Fangang Meng; Yutong Bai; Jianguo Zhang
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

3.  Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.

Authors:  Ping Zeng; Ting Wang; Junnian Zheng; Xiang Zhou
Journal:  BMC Med       Date:  2019-12-04       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.